Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Genomics AI

Genomics AI is a precision medicine company offering gamified blueprints to meet your health goals personalized by your genes.
2019
02-Oct
02-10
Bangalore, Karnataka, India
  • Consumer Healthcare
  • Nutraceuticals (e.g. Supplements)
  • Personalized Medicine Technologies
  • Services (Patient care)

Innovation

Industry Problem

Neurological disorders are biologically diverse, making diagnosis, patient selection, and treatment response difficult to predict.

R&D Focus

Genomics and multi-omics for patient stratification and treatment selection

Innovative Solution

We leverage cutting edge research in AI, metabolomics, and genomics to bring you this unique product that improves your health and wellness. Our goal is to help you understand what has always been yours and make consumer genetic testing rad(ically) popular in India.

Investment Funding

Last Funding Stage

Debt Financing

Total Funding Amount

10.K

Last Funding Amount

10.K

Last Funding Date

04-05-2020

People

Founders

About

Genomics AI is a Health-Tech company that is working on a gamified solution for you to meet all your health goals. We take a little help from your genes and devise blueprints that are personalized for the unique you! We leverage cutting edge research in AI, metabolomics, and genomics to bring you this unique product that improves your health and wellness. We found that gamifying health goals makes everyone competitive and more prone to stick to the plan. Our goal is to help you understand what has always been yours and make consumer genetic testing rad(ically) popular in India. Our offerings range from the hip weight loss (pun intended!) all the way up to utilizing your brain’s neurochemistry to its fullest, all backed by comprehensive scientific research. Our product is currently at its earliest stage of development. We know you know how much paperwork it would take to take such a unique product to the market. A closed beta will open up for the (ambitious) early adopters. We will advertise aggressively when it is ready so stay tuned for updates!

Something missing or incorrect on this page? Help us enrich this information